FIGURE

Fig. 5

ID

ZDB-FIG-240703-70

Publication

Choleva et al., 2024 - Targeting the interaction of pleiotrophin and VEGFA₁₆₅ with protein tyrosine phosphatase receptor zeta 1 inhibits endothelial cell activation and angiogenesis

Other Figures

All Figure Page

Back to All Figure Page

Fig. 5

PTN97–110 inhibits VEGFA165-induced signaling in endothelial cells. (A) HUVEC were treated with VEGFA165 (10 ng/ml) and/or PTN97-110 (100 ng/ml) for 10 min and cell lysates were analyzed by antibodies against Akt phosphorylated at Ser473 (pAkt), and total Akt (tAkt). A representative Western blot is shown (n = 3). Results are expressed as the percent pAkt/tAkt ratio compared to untreated HUVEC (set as default = 100). (B) HUVEC were treated with VEGFA165 and/or PTN97-110 for 10 min and cell lysates were analyzed by antibodies against VEGF receptor 2 phosphorylated at Tyr1175 (pVEGFR2), and total VEGF receptor 2 (VEGFR2). A representative Western blot is shown (n = 3). Results are expressed as the percent pVEGFR2/VEGFR2 ratio compared to untreated HUVEC (set as default = 100). (C) Formation of tyrosine phosphorylated VEGF receptor 2 (pVEGFR2) complexes as evidenced by in situ PLA in HUVEC cultured in the presence or absence of VEGFA165 and/or PTN97-110. Representative pictures are shown. The scale bar corresponds to 10 μm. The box plots indicate the detected signals' median, mean, and range (n = 8–10 image fields with 4–8 cells per image per sample type, each sample run in triplicate). (D) HUVEC were treated with VEGFA165 and/or PTN97-110 for 10 min and cell lysates were analyzed by antibodies against ERK1/2 phosphorylated at Tyr895 (pERK1/2), and total ERK1/2 (tERK1/2). Representative Western blots are shown (n = 3). Results are expressed as mean ± SD of the percent pERK1/2/tERK1/2 ratio compared to untreated HUVEC (set as default = 100).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image.

Reprinted from European Journal of Pharmacology, 977, Choleva, E., Menounou, L., Ntenekou, D., Kastana, P., Tzoupis, Η., Katraki-Pavlou, S., Drakopoulou, M., Spyropoulos, D., Andrikopoulou, A., Kanellopoulou, V., Enake, M.K., Beis, D., Papadimitriou, E., Targeting the interaction of pleiotrophin and VEGFA₁₆₅ with protein tyrosine phosphatase receptor zeta 1 inhibits endothelial cell activation and angiogenesis, 176692, Copyright (2024) with permission from Elsevier. Full text @ Eur. J. Pharmacol.